ALung Technologies

OverviewSuggest Edit

ALung Technologies, Inc. develops intra and extracorporeal gas exchange devices for the treatment of acute and chronic respiratory disorders. Its products include Hemolung, an extracorporeal gas exchange device that circulates blood through a small catheter; and Hattler Catheter, which is placed within the central venous blood stream in the primary vein that returns blood to the heart and is inserted directly through the skin into the vein. The company serves emphysema, chronic bronchitis, asthma with status asthmaticus, acute respiratory failure, acute respiratory distress syndrome, congestive heart failure with pulmonary edema, neonatal respiratory, and distress syndrome patients, as well as military patients. 
TypePrivate
Founded1997
HQPittsburgh, US
Websitealung.com

Latest Updates

Employees (est.) (Nov 2019)40

Key People/Management at ALung Technologies

Peter M. DeComo

Peter M. DeComo

CEO
Rachel Allen

Rachel Allen

General Counsel
Nick Kuhn

Nick Kuhn

President & COO
Frank J. Falcione

Frank J. Falcione

Senior Vice President – Regulatory Affairs and Quality
Matthew J. Burlando

Matthew J. Burlando

Vice President – Finance and Administration
Joseph Argyros

Joseph Argyros

Senior Vice President – Operations
Show more

ALung Technologies Office Locations

ALung Technologies has offices in Pittsburgh and Cambridge
Pittsburgh, US (HQ)
2500 Jane St #1
Cambridge, GB
wellington house, East Rd
Show all (2)

ALung Technologies Financials and Metrics

Summary Metrics

Founding Date

1997

ALung Technologies total Funding

$95 m

ALung Technologies latest funding size

$36 m

Time since last funding

3 years ago

ALung Technologies investors

ALung Technologies's latest funding round in April 2017 was reported to be $36 m. In total, ALung Technologies has raised $95 m
Show all financial metrics

ALung Technologies Online and Social Media Presence

Embed Graph

ALung Technologies Blogs

“Low-Flow” Versus “Mid-Flow” ECCO2R

Learn how “Low-Flow” ECCO2R with ActiveMix provides the same CO2 removal as traditional “Mid-Flow” ECCO2R devices. Read the “Low-Flow” Versus “Mid-Flow” White Paper The post “Low-Flow” Versus “Mid-Flow” ECCO2R appeared first on ALung Technologies Inc..

ActivMix Enhances CO2 Removal in the Hemolung RAS

ECCO2R effectiveness is more than blood flow and membrane surface area.  The Hemolung RAS was built for safe, simple, and effective ECCO2R by implementing ActivMix in the Hemolung RAS Cartridge.  ActivMix allows high-efficiency gas exchange at the boundary layers causing Taylor Vortices to develop t…

ALung Announces Significant Progress in its Hemolung Clinical Trial Programs

PITTSBURGH – December 10, 2018 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the achievement of major milestones in its clinical trial programs. In the Uni…

ALung hits enrollment record for clinical trial of artificial lung technology

“ALung Technologies, Inc., a Pittsburgh-based company in the respiratory health field, reached record enrollment numbers for a clinical trial of its artificial lung technology in the UK, said ALung CEO Pete DeComo.” By Julia Mericle  – Technology Reporter, Pittsburgh Business Times, September 7, 201…

Pivotal Trial of ALung’s Artificial Lung Technology Reaches Record Enrollment

The UK-based REST Trial of the Hemolung RAS is now the world’s largest trial of extracorporeal lung support. PITTSBURGH – September 4, 2018 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respir…

ALung Technologies Frequently Asked Questions

  • When was ALung Technologies founded?

    ALung Technologies was founded in 1997.

  • Who are ALung Technologies key executives?

    ALung Technologies's key executives are Peter M. DeComo, Rachel Allen and Nick Kuhn.

  • How many employees does ALung Technologies have?

    ALung Technologies has 40 employees.

  • Who are ALung Technologies competitors?

    Competitors of ALung Technologies include Vapotherm, Oticon and Advanced Medical Solutions Group.

  • Where is ALung Technologies headquarters?

    ALung Technologies headquarters is located at 2500 Jane St #1, Pittsburgh.

  • Where are ALung Technologies offices?

    ALung Technologies has offices in Pittsburgh and Cambridge.

  • How many offices does ALung Technologies have?

    ALung Technologies has 2 offices.